What does Dr. Thomas Lievens do?

Dr. Thomas Lievens is a general practice in Geel. Private Limited, started on 29 October 2021, 1 establishment.

What is the address of Dr. Thomas Lievens?

The registered office of Dr. Thomas Lievens is located at Kievermont 51, 2440 Geel.

Is Dr. Thomas Lievens still active?

Yes. According to the CBE (1 October 2026) Dr. Thomas Lievens is active, legal situation “Normale toestand”, started on 29 October 2021.

Is Dr. Thomas Lievens registered on Peppol?

Yes, Dr. Thomas Lievens is registered on the Peppol network with ID 0208:0776702061.

What is the enterprise number of Dr. Thomas Lievens?

The enterprise number of Dr. Thomas Lievens is BE0776702061.

When was Dr. Thomas Lievens founded?

Dr. Thomas Lievens was founded on 29 October 2021.

Who are the directors of Dr. Thomas Lievens?

According to the 2025 annual accounts, the directors of Dr. Thomas Lievens are: Thomas Lievens.

Is Dr. Thomas Lievens a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 October 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Thomas Lievens make in 2025?

Dr. Thomas Lievens posted a profit after taxes of € 127,350 in financial year 2025.

What is the revenue of Dr. Thomas Lievens?

As a small company, Dr. Thomas Lievens is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 182,149.

Dr. Thomas Lievens (Private Limited) - Geel

Dossier Dr. Thomas Lievens, printed on 1 October 2026 from databakkes.be/en/0776702061/dr-thomas-lievens. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Thomas Lievens from Geel, company number BE0776702061, closed financial year 2025 with a result of € 127,350 after tax. For that financial year Dr. Thomas Lievens recorded a gross margin of € 182,149 and equity of € 2,500. Compared with financial year 2024, the result moved from € 123,512 to € 127,350. Profitable, and profit is growing. The buffer shrank hard: equity is 99 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Shrank hard

€ 2,500

▼ 99% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 127,350

▲ 3% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 75,074

▲ 298% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 503,405 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 46,193

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 15,312

▼ 36% vs 2024

€ 8,750 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 962

▲ 2% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 87

▼ 99% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 159,043 Gross margin 2022: € 159,043 First fiscal year in the series	€ 195,617 Gross margin 2023: € 195,617 ▲ 23% vs 2022 (€ 159,043) Favourable step	€ 183,691 Gross margin 2024: € 183,691 ▼ 6% vs 2023 (€ 195,617) Unfavourable step	€ 182,149 Gross margin 2025: € 182,149 ▼ 1% vs 2024 (€ 183,691) Unfavourable step	▼ 1%
Profit after taxes	€ 120,782 Profit after taxes 2022: € 120,782 First fiscal year in the series	€ 134,922 Profit after taxes 2023: € 134,922 ▲ 12% vs 2022 (€ 120,782) Favourable step	€ 123,512 Profit after taxes 2024: € 123,512 ▼ 8% vs 2023 (€ 134,922) Unfavourable step	€ 127,350 Profit after taxes 2025: € 127,350 ▲ 3% vs 2024 (€ 123,512) Favourable step	▲ 3%
Equity	€ 123,282 Equity 2022: € 123,282 First fiscal year in the series	€ 256,709 Equity 2023: € 256,709 ▲ 108% vs 2022 (€ 123,282) Favourable step	€ 378,555 Equity 2024: € 378,555 ▲ 47% vs 2023 (€ 256,709) Favourable step	€ 2,500 Equity 2025: € 2,500 ▼ 99% vs 2024 (€ 378,555) Unfavourable step	▼ 99%
Total debts	€ 41,469 Total debts 2022: € 41,469 First fiscal year in the series	€ 39,315 Total debts 2023: € 39,315 ▼ 5% vs 2022 (€ 41,469) Favourable step	€ 37,870 Total debts 2024: € 37,870 ▼ 4% vs 2023 (€ 39,315) Favourable step	€ 149,449 Total debts 2025: € 149,449 ▲ 295% vs 2024 (€ 37,870) Unfavourable step	▲ 295%
Cash	€ 151,880 Cash 2022: € 151,880 First fiscal year in the series	€ 196,853 Cash 2023: € 196,853 ▲ 30% vs 2022 (€ 151,880) Favourable step	€ 18,846 Cash 2024: € 18,846 ▼ 90% vs 2023 (€ 196,853) Unfavourable step	€ 75,074 Cash 2025: € 75,074 ▲ 298% vs 2024 (€ 18,846) Favourable step	▲ 298%
Retained profit	€ 120,782 Retained profit 2022: € 120,782 First fiscal year in the series	€ 254,209 Retained profit 2023: € 254,209 ▲ 110% vs 2022 (€ 120,782) Favourable step	€ 376,055 Retained profit 2024: € 376,055 ▲ 48% vs 2023 (€ 254,209) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 376,055) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 1,494 Dividend 2023: € 1,494 Unchanged (€ 0) Unchanged	€ 1,666 Dividend 2024: € 1,666 ▲ 11% vs 2023 (€ 1,494) Unchanged	€ 503,405 Dividend 2025: € 503,405 ▲ € 501,739 vs 2024 (€ 1,666) Unchanged	▲ € 501,739
Bank debt	€ 35,000 Bank debt 2022: € 35,000 First fiscal year in the series	€ 32,812 Bank debt 2023: € 32,812 ▼ 6% vs 2022 (€ 35,000) Favourable step	€ 24,062 Bank debt 2024: € 24,062 ▼ 27% vs 2023 (€ 32,812) Favourable step	€ 15,312 Bank debt 2025: € 15,312 ▼ 36% vs 2024 (€ 24,062) Favourable step	▼ 36%
Balance sheet total	€ 164,751 Balance sheet total 2022: € 164,751 First fiscal year in the series	€ 296,024 Balance sheet total 2023: € 296,024 ▲ 80% vs 2022 (€ 164,751) Unchanged	€ 416,426 Balance sheet total 2024: € 416,426 ▲ 41% vs 2023 (€ 296,024) Unchanged	€ 151,949 Balance sheet total 2025: € 151,949 ▼ 64% vs 2024 (€ 416,426) Unchanged	▼ 64%

Key figures of Dr. Thomas Lievens, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Thomas Lievens?

What happened at Dr. Thomas Lievens in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 127,350 (▲ 3% vs 2024). Source: NBB ↗
Oct 29, 2021 New establishment in Retie. KBO
Oct 29, 2021 Start of the company according to the CBE. KBO

In short

From € 120,782 profit in 2022 to € 127,350 profit in 2025.

Paid € 150,105 in corporate taxes since 2022.

Best year ever: 2023, with € 134,922 profit.

Paid out € 506,566 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Thomas Lievens? We notify you, reason included.

Follow Dr. Thomas Lievens

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Thomas Lievens

Dr. Thomas Lievens

Behind Dr. Thomas Lievens is Thomas Lievens.

See the full network in the app

Directors

According to the 2025 annual accounts

Thomas Lievens

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Kievermont 51

2440 Geel

2.323.574.721

Nieuwstraat 8

2470 Retie

Active since 29 October 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0776.702.061
VAT number: BE 0776.702.061
Registered office: Kievermont 51, 2440 Geel
Names & denominations: Dr. Thomas Lievens
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 29 October 2021
Peppol: Active · Active since 12 Sept 2025
Activities · NACE: Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗